Redmile Group
General contacts
Investor type
PE / VC
Founded
2007
AUM
-
Location
United States
$0-1 m
Investment Ticket
3-5 years
Investment Horizon
Seed,
Series B,
Series A
Investment Stage
Sale to strategic investor,
IPO
Exit Strategy
Investor profile last updated: 07 February, 2026
Profile
Redmile Group is a company based out of San Francisco.
Redmile Group is a hedge fund and private equity management company that does venture investments, private equity, and post IPO equity investments in the healthcare industry. The company was founded in 2007 and is based in San Francisco, California. It focuses on biotechnology, healthcare, therapeutics, life sciences, and the medical devices sector. The firm has invested in companies like AlloVir, IGM Biosciences, Saluda Medical, Repare Therapeutics, ArcherDX, Augmedix, and BioNTech. As of January 2020, the firm has had 38 exits.
Industry
Region of investment
Contacts
Upgrade to see contacts
Name
Title
Email
Social Networks
If there are no contacts of this investor, please write to us, we will try to find them as
soon as possible and get back
to you!
FAQs about Redmile Group
Where is Redmile Group located?
Redmile Group is located in United States.
When was Redmile Group founded?
Redmile Group was founded in 2007.
What sectors and industries does Redmile Group invest in?
Redmile Group invests in companies and startups in Fashion/Beauty, Healthcare Services, Other, Software, Transportation, HealthTech.
What is Redmile Group geographical focus of investments?
Redmile Group invests in companies and startups in North America, Europe.
At what stages of companies and startups does Redmile Group typically invest in?
Redmile Group invests in companies and startups at Seed, Series B, Series A.
What is the usual amount of Redmile Group investment?
Redmile Group usually invests $0-1 m on average.